Cargando…

Intercalated duct cell is starting point in development of pancreatic ductal carcinoma?

BACKGROUND: Although it is well known that the pancreatic ductal carcinoma may develop having a relationship to the mucous gland hyperplasia (MGH) with atypia (PanIN-1B by PanIN system), the starting point of this atypical MGH is unclear. To know it, we examined the pancreas tissue using many method...

Descripción completa

Detalles Bibliográficos
Autores principales: Wada, Ryo, Ogawa, Kaoru, Yamaguchi, Toshikazu, Tanizaki, Takayuki, Matsumoto, Michio
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1185555/
https://www.ncbi.nlm.nih.gov/pubmed/16018800
http://dx.doi.org/10.1186/1477-3163-4-9
_version_ 1782124739574104064
author Wada, Ryo
Ogawa, Kaoru
Yamaguchi, Toshikazu
Tanizaki, Takayuki
Matsumoto, Michio
author_facet Wada, Ryo
Ogawa, Kaoru
Yamaguchi, Toshikazu
Tanizaki, Takayuki
Matsumoto, Michio
author_sort Wada, Ryo
collection PubMed
description BACKGROUND: Although it is well known that the pancreatic ductal carcinoma may develop having a relationship to the mucous gland hyperplasia (MGH) with atypia (PanIN-1B by PanIN system), the starting point of this atypical MGH is unclear. To know it, we examined the pancreas tissue using many methods described below. METHODS: 1. Twenty-seven surgically resected pancreas tissue specimens, including pancreatic ductal carcinomas (PDC), chronic pancreatitis and normal pancreas, were investigated using immunohistochemical stainings for MUC1, MUC6, 45M1, Ki67 and p53. 2. DNA extraction and analysis of K-ras mutation at codon 12 using microdissection method: The paraffin blocks with 16 regions including the intercalated duct cell (IC) adjacant to the atypical MGH were prepared for DNA extraction. Mutation of K-ras codon 12 was analized and compared in enriched polymerase chain reaction-enzyme-linked minisequence assay (PCR-ELMA). RESULTS: 1. In the normal pancreas, although no positive cell was seen in 45M1, p53, Ki67, the cytoplasm of IC were always positive for MUC1 and sometimes positive for MUC6. In the pancreas with fibrosis or inflammation, MGH was positive for MUC6 and 45M1. And atypical MGH was positive for MUC1, MUC6 and 45M1. Some IC adjacent to the atypical MGH was positive for Ki67 as well as atypical MGH. The carcinoma cells in all cases of PDC were diffusely positive for MUC1, 45M1, p53 and Ki67, and focally positive for MUC6. 2. In K-ras mutation, we examined the regions including IC adjacent to the atypical MGH, because the immunohistochemical apomucin stainings of these regions resembled those of PDC as decribed above. And K-ras mutation was confirmed in 12 of 16 regions (75%). All mutations were a single mutation, in 6 regions GTT was detected, in 4 regions GAT was detected and in 2 region AGT was detected. CONCLUSION: Some intercalated duct cell may be the starting point of the pancreatic ductal carcinoma, because the exhibitions of mucin expressions, Ki67, p53 and K-ras mutation in some intercalated duct cell resembled those of mucous gland hyperplasia or pancreatic ductal carcinoma.
format Text
id pubmed-1185555
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-11855552005-08-13 Intercalated duct cell is starting point in development of pancreatic ductal carcinoma? Wada, Ryo Ogawa, Kaoru Yamaguchi, Toshikazu Tanizaki, Takayuki Matsumoto, Michio J Carcinog Research BACKGROUND: Although it is well known that the pancreatic ductal carcinoma may develop having a relationship to the mucous gland hyperplasia (MGH) with atypia (PanIN-1B by PanIN system), the starting point of this atypical MGH is unclear. To know it, we examined the pancreas tissue using many methods described below. METHODS: 1. Twenty-seven surgically resected pancreas tissue specimens, including pancreatic ductal carcinomas (PDC), chronic pancreatitis and normal pancreas, were investigated using immunohistochemical stainings for MUC1, MUC6, 45M1, Ki67 and p53. 2. DNA extraction and analysis of K-ras mutation at codon 12 using microdissection method: The paraffin blocks with 16 regions including the intercalated duct cell (IC) adjacant to the atypical MGH were prepared for DNA extraction. Mutation of K-ras codon 12 was analized and compared in enriched polymerase chain reaction-enzyme-linked minisequence assay (PCR-ELMA). RESULTS: 1. In the normal pancreas, although no positive cell was seen in 45M1, p53, Ki67, the cytoplasm of IC were always positive for MUC1 and sometimes positive for MUC6. In the pancreas with fibrosis or inflammation, MGH was positive for MUC6 and 45M1. And atypical MGH was positive for MUC1, MUC6 and 45M1. Some IC adjacent to the atypical MGH was positive for Ki67 as well as atypical MGH. The carcinoma cells in all cases of PDC were diffusely positive for MUC1, 45M1, p53 and Ki67, and focally positive for MUC6. 2. In K-ras mutation, we examined the regions including IC adjacent to the atypical MGH, because the immunohistochemical apomucin stainings of these regions resembled those of PDC as decribed above. And K-ras mutation was confirmed in 12 of 16 regions (75%). All mutations were a single mutation, in 6 regions GTT was detected, in 4 regions GAT was detected and in 2 region AGT was detected. CONCLUSION: Some intercalated duct cell may be the starting point of the pancreatic ductal carcinoma, because the exhibitions of mucin expressions, Ki67, p53 and K-ras mutation in some intercalated duct cell resembled those of mucous gland hyperplasia or pancreatic ductal carcinoma. BioMed Central 2005-07-14 /pmc/articles/PMC1185555/ /pubmed/16018800 http://dx.doi.org/10.1186/1477-3163-4-9 Text en Copyright © 2005 Wada et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Wada, Ryo
Ogawa, Kaoru
Yamaguchi, Toshikazu
Tanizaki, Takayuki
Matsumoto, Michio
Intercalated duct cell is starting point in development of pancreatic ductal carcinoma?
title Intercalated duct cell is starting point in development of pancreatic ductal carcinoma?
title_full Intercalated duct cell is starting point in development of pancreatic ductal carcinoma?
title_fullStr Intercalated duct cell is starting point in development of pancreatic ductal carcinoma?
title_full_unstemmed Intercalated duct cell is starting point in development of pancreatic ductal carcinoma?
title_short Intercalated duct cell is starting point in development of pancreatic ductal carcinoma?
title_sort intercalated duct cell is starting point in development of pancreatic ductal carcinoma?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1185555/
https://www.ncbi.nlm.nih.gov/pubmed/16018800
http://dx.doi.org/10.1186/1477-3163-4-9
work_keys_str_mv AT wadaryo intercalatedductcellisstartingpointindevelopmentofpancreaticductalcarcinoma
AT ogawakaoru intercalatedductcellisstartingpointindevelopmentofpancreaticductalcarcinoma
AT yamaguchitoshikazu intercalatedductcellisstartingpointindevelopmentofpancreaticductalcarcinoma
AT tanizakitakayuki intercalatedductcellisstartingpointindevelopmentofpancreaticductalcarcinoma
AT matsumotomichio intercalatedductcellisstartingpointindevelopmentofpancreaticductalcarcinoma